Literature DB >> 1233219

Effects of metoprolol and propranolol on furosemide-stimulated renin release in healthy subjects.

P O Attman, M Aurell, G Johnsson.   

Abstract

The effects of single doses of the beta1-receptor antagonist metoprolol (40 mg orally), propranolol (40 mg orally) and placebo were compared on furosemide-stimulated plasma renin activity (PRA) in seven healthy subjects. In the placebo studies, PRA increased by 0.59+/-0.18 ng x ml-1 x h-1 60 minutes after intravenous administration of 30-60 mg furosemide. After propranolol and metoprolol, the corresponding increases in PRA were significantly less pronounced amounting to 0.16+/-0.06 and 0.24+/-0.08 ng x ml-1 x h-1, respectively. The resting heart rate was reduced to the same extent after the two beta-blockers, which means that the two drugs had been given in equipotent beta1-receptor blocking doses. It is suggested that the release of renin from the kidney may partly be mediated via an adrenergic beta1-receptor.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233219     DOI: 10.1007/bf00567115

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Influence of metoprolol and propranolol on hemodynamic effects induced by physical work and isoprenaline.

Authors:  G Johnsson; G Nyberg; L Sölvell
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

2.  Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol.

Authors:  G Johnsson; C G Regårdh; L Sölvell
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

3.  Plasma renin concentration measured by use of radioimmunoassay for angiotensin I.

Authors:  J Giese; M Jörgensen; M D Nielsen; J O Lund; O Munck
Journal:  Scand J Clin Lab Invest       Date:  1970-12       Impact factor: 1.713

4.  Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

Authors:  F R Bühler; J H Laragh; E D Vaughan; H R Brunner; H Gavras; L Baer
Journal:  Am J Cardiol       Date:  1973-09-20       Impact factor: 2.778

5.  Peripheral and renal venous plasma renin concentration in hypertensive patients with unilateral renal or renovascular disease.

Authors:  J Giese; M Aurell; O Munck
Journal:  Scand J Urol Nephrol       Date:  1972

6.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

7.  Acute changes in plasma volume, renin activity, and free aldosterone levels in healthy subjects following Fursemide administration.

Authors:  J Rosenthal; R Boucher; W Nowaczynski; J Genest
Journal:  Can J Physiol Pharmacol       Date:  1968-01       Impact factor: 2.273

8.  Plasma renin activity after the use of a new beta-adrenergic blocking agent (I.C.I. 66,032).

Authors:  H Aberg
Journal:  Int J Clin Pharmacol       Date:  1974-03

9.  Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics.

Authors:  G Johnsson; N Svedmyr; G Thiringer
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

10.  Plasma renin levels and vascular complications in hypertension.

Authors:  A E Doyle; G Jerums; C I Johnston; W J Louis
Journal:  Br Med J       Date:  1973-04-28
View more
  12 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

2.  Effects of salbutamol and metoprolol on plasma renin activity and plasma potassium of normal subjects and of hypertensive patients.

Authors:  A Salvetti; L Poli; F Arzilli; L Sassano; R Pedrinelli; M Motolese
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

Review 3.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

4.  Evidence for the participation of beta1-adrenoceptors in isoprenaline-induced renin release from rat kidny slices in vitro.

Authors:  E Desaulles; F Miesch; J Schwartz
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

5.  Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol.

Authors:  S Sonkodi; E Agabiti-Rosei; R Fraser; B J Leckie; J J Morton; A M Cumming; V P Sood; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

Review 6.  [The influence of beta-receptor blockers on metabolism (author's transl)].

Authors:  F W Lohmann
Journal:  Klin Wochenschr       Date:  1981-01-15

7.  The effects of beta-adrenoceptor blockade on renin, angiotensin, aldosterone and catecholamines at rest and during exercise.

Authors:  P J Lijnen; A K Amery; R H Fagard; T M Reybrouck; E J Moerman; A F De Schaepdryver
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

8.  Lack of adrenergic influence on renin release after furosemide in normal man.

Authors:  J Elmgreen; B Hesse; N J Christensen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  The effect of propranolol on urinary prostaglandin E2 after frusemide administration in healthy subjects.

Authors:  A Fujimura; H Kajiyama; A Ebihara
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension.

Authors:  E Fritschka; R Gotzen; R Kittler; M Schöneshöfer
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.